Fig. 3From: The efficacy of intra-articular triamcinolone acetonide 10 mg vs. 40 mg in patients with knee osteoarthritis: a non-inferiority, randomized, controlled, double-blind, multicenter studyTreatment effects of triamcinolone acetonide 10 and 40 mg on secondary efficacy outcomes including WOMAC pain subscale (a), WOMAC stiffness subscale (b), EQ5D assessment (c) and global visual analog scale assessment (d)Back to article page